FDA approves Novo Nordisk fast-acting insulin Fiasp Ruby Khatun Khatun4 Oct 2017 4:27 AMThe U.S. Food and Drug Administration (FDA) on Friday approved Novo Nordisk's fast-acting insulin to treat diabetes.The product, known as Fiasp, is...
